Seeking Alpha · ORIC · October 23, 2026

ORIC Pharmaceuticals, Inc. (ORIC) Discusses Enozertinib Phase Ib Data and Commercial Opportunity in EGFR Atypical Non-Small Cell Lung Cancer Transcript

Get the app for more

Explore stock news, insights and company research.